ArticleClinical drug investigation2019

Adverse Event Profiles of Anti-CTLA-4 and Anti-PD-1 Monoclonal Antibodies Alone or in Combination: Analysis of Spontaneous Reports Submitted to FAERS.

Huan-Huan Ji et al.PubMed ↗Publisher ↗

No numbers read from the abstract.